Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of JMKX003142 tablets in rapidly progressive autosomal dominant polycystic kidney disease
CTR20250172Phase 2Active
- Sponsor
- Zhejiang Hangyu Pharmaceutical
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JMKX003142 in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Zhejiang Hangyu Pharmaceutical. Started Mar 2025; status: active.
02
Drugs
JMKX003142
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on CTR20250172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250172.